EUVIMEDEUVIMED entdecken
CrossrefInfokarte

Dynamic course and outcomes of acute-on-chronic liver failure in the intensive care unit

Patrick Haselwanter, Max Oberweger, Marian Strunz, Petrus Aho, Lorenz Balcar, Georg Semmler, Benedikt Simbrunner, Bernhard Scheiner, Albert Friedrich Stättermayer, Marlene Riedl-Wewalka, Monika Schmid, Thomas Reiberger, Michael Trauner, Christian Zauner, Mathias Schneeweiss-Gleixner

Wiener klinische Wochenschrift · 2026-10-13

DOI: 10.1007/s00508-026-02829-2 ↗
AbstractBibliografische Angaben

Abstract

Summary Background Acute-on-chronic liver failure (ACLF) frequently requires intensive care unit (ICU) management, yet real-world data on dynamic disease course, organ support and mortality predictors in critically ill ACLF patients remain scarce. Methods All ACLF patients admitted to a tertiary care hepatology ICU between 2013 and 2023 were analyzed in this retrospective single-center study for ACLF grade trajectories, organ support, and independent predictors of 90-day mortality. Results Among 209 patients (228 admissions), 54.4% had ACLF grade 3 at ICU admission (median CLIF‑C ACLF 56). Most patients required vasopressors (86.8%), invasive mechanical ventilation (59.6%), and renal replacement therapy (53.5%). The ICU and 90-day survival were 56.1% and 34.2%, respectively. One third of the patients (33.3%) showed improvement in ACLF grade during the ICU stay, including grade 3 patients, indicating meaningful reversibility under comprehensive organ support. The CLIF‑C ACLF score (OR: 1.07, 95% CI: 1.03–1.11, p < 0.001) and the peak noradrenaline dose (OR: 13.5, 95% CI: 3.18–69.7, p < 0.001) were identified as independent predictors of 90-day mortality. Conclusion Critically ill ACLF patients retain potential for partial recovery under full organ support, justifying ICU escalation even in grade 3 disease. Peak noradrenaline dose, alongside the established prognostic scores, provides a readily available parameter to guide individualized decision-making regarding full organ support or timely de-escalation.

Wissen, das zu Ihrer Arbeit passt.

Vom kostenlosen Einstieg über die persönliche Recherche bis zur vollständigen Research Suite.

Tarife ansehen →

Sind alle Verlagsvolltexte enthalten?

Nein. Bibliografische Nachweise, Abstracts und Volltexte sind unterschiedliche Inhalte. Ob ein Volltext verfügbar ist, hängt von der Quelle, Open Access und Ihren vorhandenen Lizenzen ab. Ein EUVIMED-Tarif ersetzt keine zusätzlichen Verlagsrechte.

Tarife ansehen →